Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial.

ABSTRACT:

Background

In the multicentre randomized trial BRIOS (Breast Reconstruction In One Stage), direct-to-implant (DTI) breast reconstruction with an acellular dermal matrix (ADM) was associated with a markedly higher postoperative complication rate compared with two-stage tissue expander/implant breast reconstruction. This study aimed to identify factors that contribute to the occurrence of complications after DTI ADM-assisted breast reconstruction.

Methods

Data were obtained from the BRIOS study, including all patients treated with DTI ADM-assisted breast reconstruction. Logistic regression analyses were performed to identify factors predictive of postoperative complications.

Results

Fifty-nine patients (91 breasts) were included, of whom 27 (35 breasts) developed a surg

SUBMITTER: Negenborn VL 

PROVIDER: S-EPMC6099293 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature